Stocks › AMGN
AMGEN INC
AMGN·Nasdaq·
United States·USD
United States·USD$402.60
-0.38 (-0.09%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
AMGN
AMGEN INC · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AMGNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of AMGN by members of U.S. Congress · 235 on record · 24 in the last 12 months
Whale Activity
Position changes in AMGN reported for 2026-09-30 by 16 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased2
- Closed0
- No prior filing14
| Filer | Shares | Value | Change |
|---|---|---|---|
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | 243.7K | $102.7M | — |
| ARGENT CAPITAL MANAGEMENT LLC | 69.5K | $29.3M | — |
| CapWealth Advisors, LLC | 58.6K | $24.7M | — |
| TOMPKINS FINANCIAL CORP | 45.8K | $19.3M | — |
| Coastline Trust Co | 16.7K | $7.0M | decreased |
| Stonebridge Financial Group, LLC | 15.8K | $6.7M | — |
| Iowa State Bank | 9,548 | $4.0M | — |
| Violich Capital Management, Inc. | 8,150 | $3.4M | — |
| Bangor Savings Bank | 5,293 | $2.2M | — |
| DOLIVER ADVISORS, LP | 4,450 | $1.9M | — |
| HALL LAURIE J TRUSTEE | 4,412 | $1.9M | decreased |
| ABLES, IANNONE, MOORE & ASSOCIATES, INC. | 2,558 | $1.1M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by AMGN insiders, by quarter · Form 4
Recent Insider Transactions
2,538 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Khosla RachnaSVP, Business Development | Sale | −1,252 | $416.43 | $521K | Aug 13, 2026 | Form 4 ↗ |
| Khosla RachnaSVP, Business Development | Sale | −2,000 | $412.57 | $825K | Aug 11, 2026 | Form 4 ↗ |
| Miller DerekSVP, Human Resources | Sale | −2,069 | $402.54 | $833K | Aug 6, 2026 | Form 4 ↗ |
| Miller DerekSVP, Human Resources | Sale | −1,821 | $402.54 | $733K | Aug 6, 2026 | Form 4 ↗ |
| Grygiel Nancy A.SVP & CCO | Sale | −1,970 | $402.16 | $792K | Aug 6, 2026 | Form 4 ↗ |
| Grygiel Nancy A.SVP & CCO | Sale | −1,000 | $402.16 | $402K | Aug 6, 2026 | Form 4 ↗ |
| MILES AMY EDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Kullman Ellen JamisonDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Klotman Mary E.Director | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Jacks TylerDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| ISHRAK OMARDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| HOLLEY CHARLES MDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Garland Greg C.Director | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| ECKERT ROBERTDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Druker BrianDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Drake Michael VDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Austin Wanda MDirector | Grant / award | +665 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Busch Matthew C.VP, Finance & CAO | Tax withholding | −41 | $331.11 | $14K | May 7, 2026 | Form 4 ↗ |
| Santos EstebanEVP, Operations | Tax withholding | −522 | $331.11 | $173K | May 7, 2026 | Form 4 ↗ |
| REESE DAVID MEVP & Chief Technology Officer | Tax withholding | −556 | $331.11 | $184K | May 7, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding AMGN · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 17.1M | $6.20B | 0.27% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 14.0M | $5.07B | 0.30% | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | 11.5M | $4.15B | 0.85% | Jun 30, 2026 |
| Schwab U.S. Dividend Equity ETF SCHWAB STRATEGIC TRUST | 9.8M | $3.30B | 3.47% | May 31, 2026 |
| Income Fund of America | 7.8M | $2.99B | 2.02% | Jul 31, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 7.4M | $2.69B | 0.30% | Jun 30, 2026 |
| American Balanced Fund | 7.1M | $2.57B | 0.89% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 6.5M | $2.37B | 0.30% | Jun 30, 2026 |
| Washington Mutual Investors Fund | 6.1M | $2.33B | 1.07% | Jul 31, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 6.9M | $2.32B | 0.28% | May 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list AMGN's shares (CUSIP 031162100), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Capital World InvestorsSCHEDULE 13G · passive (13G) · 29.6M shares5.5%
May 14, 2026 · ↗ - Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 40.5M shares7.5%
Apr 29, 2026 · ↗ - The Vanguard GroupSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Mar 26, 2026 · ↗ - The Vanguard GroupSCHEDULE 13G/A · passive (13G) · 53.9M shares10.0%
Sep 8, 2025 · ↗ - BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 40.8M shares7.6%
Apr 17, 2025 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming amgen as client
- MR. DAN CRIPPENAMGEN · 2026 Q2—
Filing ↗ - FEDERAL HEALTH COUNSEL, LLCAMGEN, INC. · 2026 Q2 · MMM—
Filing ↗ - TODD STRATEGY GROUPAMGEN INC. · 2026 Q2 · MMM, HCR, TAX$80K
Filing ↗ - THE NICKLES GROUP, LLCAMGEN · 2026 Q2 · MMM, HCR, CPT, TAX$60K
Filing ↗ - AMGEN, INC.AMGEN INC · 2026 Q2 · HCR, MMM, TAX, CPT$2.4M
Filing ↗
Government Contracts
Federal awards to AMGEN INC · USAspending
No federal contract awards found for AMGEN INC.
U.S. Patents
Recent USPTO applications naming AMGEN INC
No USPTO patent applications found for AMGEN INC.
Annual Financials
From AMGN's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $36.75B | $33.42B | $28.19B | $26.32B | $25.98B |
| Operating income | $9.08B | $7.26B | $7.90B | $9.57B | $7.64B |
| Net income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B |
| Diluted EPS | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 |
| Operating cash flow | $9.96B | $11.49B | $8.47B | $9.72B | $9.26B |
| Cash and equivalents | $9.13B | $11.97B | $10.94B | $7.63B | $7.99B |
| Total assets | $90.59B | $91.84B | $97.15B | $65.12B | $61.16B |
| Shareholders' equity | $8.66B | $5.88B | $6.23B | $3.66B | $6.70B |
As AMGEN INC tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 13, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitNov 22, 1999
- 2-for-1Stock splitMar 1, 1999
- 2-for-1Stock splitAug 16, 1995
- 3-for-1Stock splitSep 11, 1991
- 2-for-1Stock splitAug 13, 1990
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsAug 4, 2026
EDGAR ↗ - 8-K · Items 1.05Jul 31, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 20, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeMay 19, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsApr 30, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeApr 22, 2026
EDGAR ↗ - 8-K · Items 1.01, 9.01Material agreementFeb 19, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsFeb 3, 2026
EDGAR ↗ - 8-K · Items 1.02, 9.01Termination of agreementJan 30, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsNov 4, 2025
EDGAR ↗
About AMGEN INC
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersTHOUSAND OAKS, CA
IncorporatedDE
SEC CIK0000318154 ↗